LOGIN  |  REGISTER
Assertio

Encompass Health and Piedmont announce plans to build a 40-bed inpatient rehabilitation hospital in Loganville, Georgia

March 07, 2024 | Last Trade: US$100.23 1.11 -1.10

BIRMINGHAM, Ala. and LOGANVILLE, Ga., March 7, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) and Piedmont today announced they have been awarded a certificate of need to build a freestanding, 40-bed inpatient rehabilitation hospital in Loganville, Georgia. The hospital will be located at 3195 Loganville Highway. When the Loganville hospital opens, Piedmont intends to relocate its existing 20-bed rehabilitation unit at Piedmont Eastside Medical Center to the new hospital.

The hospital will care for patients recovering from debilitating illnesses and injuries including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions. Complementing local acute care services, the future hospital will offer physical, occupational, and speech therapies and 24-hour nursing care to restore functional ability and quality of life. The hospital will feature all private patient rooms, a spacious therapy gym with advanced rehabilitation technologies, and activities of daily living suite, cafeteria, pharmacy, and therapy courtyard.

"We are excited to continue expanding our partnership with Piedmont, a well‑respected integrated healthcare leader that has been serving Georgia residents for more than a century," said Ronnie Wagley, President of Encompass Health's South Atlantic Region. "By leveraging the strengths of both organizations, we look forward to serving more patients and providing high‑quality, rehabilitative care to residents in the East Atlanta area and beyond."

"We are honored to serve patients in Gwinnett County and the surrounding communities, now in partnership with Encompass Health," said Larry Ebert, CEO of Piedmont Eastside Hospital. "We look forward to building a rehabilitation facility where patients can regain function, strength, hope, and independence before rejoining the community."

About Piedmont Healthcare

Piedmont is empowering Georgians by changing health care. We continue to fuel Georgia's growth through safe, high-quality care close to home through an integrated health care system that provides a hassle-free, unified experience. We are a private, not-for-profit organization with more than 12,000 donors annually that for centuries has sought to make a positive difference in every life we touch in the communities we serve. Across our 1,600 physical locations we care for 3.7 million patients and serve communities that comprise 80 percent of Georgia's population. This includes 23 hospitals, 65 Piedmont Urgent Care centers, 25 QuickCare locations, 1,875 Piedmont Clinic physician practices and nearly 3,100 Piedmont Clinic members. Our patients conveniently engage with Piedmont online, as they scheduled more than 515,000 online appointments and over 154,000 virtual visits. With more than 44,000 care givers we are the largest Georgia-based private employer of Georgians, who all came for the job, but stayed for the people. In 2023, Piedmont has earned recognition from Newsweek as one of America's Greatest Workplaces for Diversity and also as one of America's Greatest Workplaces for Women. In 2022, Forbes ranked Piedmont on its list of the Best Large Employers in the United States. In addition, Piedmont provided nearly $360 million in Community Benefit in Fiscal Year 2022, including approximately $310 million in uncompensated care.

For more information, or booking your next appointment, visit piedmont.org

About Encompass Health

Encompass Health (NYSE: EHC) is the largest owner and operator of rehabilitation hospitals in the United States. With a national footprint that includes 160 hospitals in 37 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies and Modern Healthcare's Best Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter, Instagram and Facebook.

FORWARD-LOOKING STATEMENTS

Statements contained in this press release which are not historical facts, such as those relating to the likelihood, timing and effects of the completion of this and other hospital projects, are forward-looking statements. In addition, Encompass Health may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Encompass Health's actual results or events may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results or events to differ materially from those anticipated include, but are not limited to, the regulatory review and approval process, any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings that may be brought by or against the Company; the possibility this project will experience unexpected delays; the ability to successfully complete this project consistent with Encompass Health's growth strategy, including realization of anticipated revenues and avoidance of unforeseen exposure to liabilities;  disease outbreaks, including the speed, depth, geographic reach and duration of the spread; the actions to be taken by Encompass Health in response to disease outbreaks; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and Encompass Health's response thereto; the hospital's ability to maintain proper local, state and federal licensing; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on Encompass Health's labor expenses from potential union activity and staffing shortages; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; general conditions in the economy and capital markets; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended Dec. 31, 2023.

Encompass Health contacts:
Media contact:
Kennedi Spurling | 205-970-5912
This email address is being protected from spambots. You need JavaScript enabled to view it.

            

Piedmont contact:
Media contact: Alexis Scott | 470-446-8342
This email address is being protected from spambots. You need JavaScript enabled to view it.

              

Investor Relations contact: Mark Miller | 205-970-5860
This email address is being protected from spambots. You need JavaScript enabled to view it.

             

 

Viking Therapeutics

Stock Quote

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB